Skip to content

A Comparison Between Hemodialysis and Pre-dilution High Volume Online Hemodiafiltration for The Removal of Protein-bound Uremic Toxins Using Super High-flux Dialyzers: A Randomized Prospective Crossover Equality Study

A Comparison Between Hemodialysis and Pre-dilution High Volume Online Hemodiafiltration for The Removal of Protein-bound Uremic Toxins Using Super High-flux Dialyzers: A Randomized Prospective Crossover Equality Study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240425003
Enrollment
14
Registered
2024-04-25
Start date
2023-11-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Protein bound uremic toxins removal in chronic hemodialysis Small, middle and large molecular weight uremic toxins removal in chronic hemodialysis patients Super High-flux dialyzers Medium cut-off membrane Online hemodiafiltration Indoxyl sulfate Dialysate albumin loss

Interventions

Chronic hemodialysis patients use super-high flux dialyzer with hemodialysis for 8 weeks.,Chronic hemodialysis patients use super-high flux dialyzer with pre-dilution online hemodiafiltration for 8 we
Experimental Other,Experimental Other
SHF-HDF,SHF-HD

Sponsors

Faculty of Medicine, Chulalongkorn University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Days to 90 Years

Inclusion criteria

Inclusion criteria: Hemodialysis patients with dialysis vintage at King Chulalongkorn Memorial hospital for more than 3 months Adequate hemodialysis by Kt/V as the recommended guideline Urine output less than 100 ml/day Stable hemodynamic for at least 2 weeks before entering the research

Exclusion criteria

Exclusion criteria: Active cardiovascular disease, active severe infection Severe dialyzer allergy Malnutrition requiring intradialytic parenteral nutrition Cirrhosis child C or decompensated cirrhosis Advance stage malignancy Have a chance to get living related kidney transplant within 1 year Unwilling to participate the project

Design outcomes

Primary

MeasureTime frame
Free and total indoxyl sulfate reduction ratio at 8 weeks after the end of each intervention Percent

Secondary

MeasureTime frame
Kappa and lambda free light chain reduction ratio at 8 weeks after the end of each intervention Percent,Beta-2 microglobulin reduction ratio at 8 weeks after the end of each intervention Percent,Urea reduction ratio at 8 weeks after the end of each intervention Percent,Dialysate albumin loss at 1st and 8th weeks of the intervention gram per session

Countries

Thailand

Contacts

Public ContactRossanun Shoosanglertwijit

Faculty of Medicine, Chulalongkorn university

lily_rossanun@hotmail.com0899893388

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026